繁體
简体中文
繁體中文

CorVel CRVL

等待開盤 09-30 09:30:00 美东时间

77.22

-1.420

-1.81%

华盛通華盛通
立即下載
  • 最 高79.255
  • 今 開78.74
  • 成交量 13.25万股
  • 最 低 77.10
  • 昨 收 78.64
  • 總市值 39.62亿
  • 52周最高 128.61
  • 市盈率 42.19
  • 換手率 0.00%
  • 52周最低 77.10
  • 委 比 92.31%
  • 總股本 5131.27万
  • 歷史最高 128.61
  • 量 比 0.78
  • 振 幅 2.74%
  • 歷史最低 9.36
  • 每 手 1
  • 風險率 11.08%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • 稳定币公链化:从价值依附到价值捕获的新格局

    稳定币市场快速发展,总流通量达2870亿美元,USDT和USDC占据主导地位。然而,发行方在依赖公链的同时获利有限,促使越来越多的发行方开始自建公链。例如,Tether推出Plasma和Stable链,Circle推出Arc链,这些新链旨在优化交易体验、降低用户门槛并提高合规性。通过自建公链,发行方不仅能够增强价值捕获,还能拓展多元化商业模式。未来,稳定币公链将与传统公链形成分工互补,推动加密市场进入“稳定币—公链双轮驱动”的新阶段。

    09-22 13:23

  • Three CorVel Partners Recognized as 2025 Theo Award Winners for Excellence in Workers’ Compensation

    CorVel Corporation announced the 2025 Theo Award winners: Sharp HealthCare, State of North Carolina, and The Save Mart Companies. These organizations were recognized for innovative approaches in workers’ compensation, including biopsychosocial care, disaster response, and workplace safety. Sharp HealthCare’s transdisciplinary model improved recovery outcomes for complex injuries. North Carolina excelled in crisis management during Hurricane Helen...

    09-10 11:22

  • The Save Mart Companies Honored for Transforming Workers’ Comp Program in Collaboration with CorVel

    The Save Mart Companies, a leading West Coast grocery chain, has been awarded the 2025 Workers’ Compensation Risk Management Award for Excellence for its innovative risk management strategies. Partnering with CorVel, they implemented proactive measures, including a 24/7 nurse triage line, data-driven safety initiatives, and collaborative claims reviews, leading to a 25% reduction in new claims in 2024. At high-risk locations, claims dropped by 43...

    08-26 11:12

  • Critical Metals Corp Engages Global Engineering Firm NIRAS to Finalize DFS for Tanbreez in Greenland

    Critical Metals Corp (NASDAQ: CRML) announced that Tanbreez Mining Greenland A/S has appointed NIRAS A/S to complete a Definitive Feasibility Study (DFS) for a 500,000 metric tons per annum mining and processing operation at the Tanbreez Rare Earth Project in southern Greenland. The DFS will cover technical, environmental, and commercial aspects, with completion expected in Q4 2025. Critical Metals holds a controlling interest in the project and ...

    08-07 12:00

  • CorVel Reports Strong Quarterly Earnings Growth

    Corvel ( ($CRVL) ) has released its Q1 earnings. Here is a breakdown of the inf...

    08-06 12:28

  • CorVel Announces Revenues and Earnings

    CorVel Corporation reported Q2 2025 revenue of $235M, up 11% YoY, with EPS of $0.52, a 24% increase. Gross profit rose 18% to $56.8M. The company ended the quarter with $202M in cash and repurchased $9.6M in stock. A technology assets acquisition was completed to bolster CERIS capabilities, expected to drive future growth.

    08-05 10:15

  • Carbon Revolution Secures Final Release of $5 Million from OIC and Final $0.4 Million Reserve Release from Existing Lenders

    Carbon Revolution plc received US$5 million from Orion Infrastructure Capital (OIC), completing the US$25 million facility. Additionally, Existing Noteholders released the final US$400,000, raising total reserves to US$2 million. The company issued 5% warrants to OIC and noteholders. The firm faces reduced revenue forecasts due to lower wheel orders and delayed customer payments, slowing expansion plans. They are exploring further financing withi...

    07-25 20:30

  • Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

    Corvus Pharmaceuticals announced that its leadership team will participate in one-on-one investor meetings and present a corporate overview at the 2025 Jefferies Global Healthcare Conference in New York on June 5, 2025. The presentation will be available via webcast, accessible through the company's investor relations website for 90 days post-event. Corvus specializes in developing ITK inhibition for cancer and immune disease treatments.

    05-28 20:01

  • CorVel Q4 EPS $0.51 Up From $0.37 YoY, Sales $231.51M Up From $207.23M YoY

    CorVel (NASDAQ:CRVL) reported quarterly earnings of $0.51 per share. This is a 37.84 percent increase over earnings of $0.37 per share from the same period last year. The company reported $231.51 million in sales this

    05-22 18:17

  • CorVel Corporation Reports Strong Quarterly Earnings

    Corvel ( ($CRVL) ) has released its Q3 earnings. Here is a breakdown of the inf...

    02-11 11:53